ArticleAllergy2022

Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.

Matthew Plassmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.